Mesh Vs Pledgets for Repair of Paraesophageal Hernia
A Randomized, Blinded, Parallel-group Trial Evaluating Mesh Versus Pledgeted Sutures in Paraesophageal Hernia Recurrence
David Krpata
164 participants
Sep 11, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare whether the use of Ovitex mesh provides superior reduction in 2-year recurrence compared to pledgeted suture closure (no mesh) for patients undergoing paraesophageal hernia repair at the Cleveland Clinic. The main questions it aims to answer are: * Determine whether there is a difference in 2-year rates of radiographic recurrence with Ovitex versus pledgeted sutures in paraesophageal hernia repair. * Assess patient quality of life (QOL) after paraesophageal hernia repair with pledgets and mesh. A two-tailed research hypothesis will be used to determine whether there are differences between the two arms
Eligibility
Inclusion Criteria4
- years of age or older
- Willing and able to provide informed consent
- Willing and able to participate in long-term follow up including study visits and surveys
- Type II, III, or IV hiatal hernia \> 5 cm, confirmed via upper GI studies, CT, or MRI 5 cm or greater hernia confirmed intraoperatively
Exclusion Criteria5
- Pregnancy
- BMI \>45
- Allergy to any components of mesh
- Patients undergoing PEHR with a concurrent bariatric procedure or other procedure to reduce stomach volume (sleeve gastrectomy, roux-en-y gastric bypass, duodenal switch, single-anastomosis gastric bypass, and partial or total gastrectomy)
- Patients who have undergone previous hiatal hernia repair
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patient will receive Ovitex Mesh (TELA Bio)
Patient will receive pledgeted sutures
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05974722